Do you have a furry best friend who is suffering from anxiety or chronic pain? One Australian medical cannabis company, Creso Pharma, says they have a solution for your troubled dog or cat.
The European Union just gave Creso a health registration to sell two cannabidiol-based products for pets: one for horses, and one for smaller animals like dogs and cats. They say the products can be used to treat “behavioral based disorders such as anxiety and noise phobias, chronic pain, arthritis and diabetes”.
The studies backing up the claim are still limited, with evidence based on anecdotal trials and preclinical studies on rats. But that’s not keeping pet owners, and even some vets, from singing the praises of the treatment.
Veterinarian Edward Bassingthwaighte says he has been utilizing cannabis as a treatment for dogs for a long time. He says it has given significant relief to dogs who are dealing with age-related illnesses like arthritis.
Though he says dogs can get drowsy with high doses, Creso’s products contain only cannabidiol, no THC, so there are no psychoactive effects for the pets. Don’t worry, no one is getting their furry friends high without their permission.
Creso’s CEO, Dr Miri Halperin Wernli, praised the development, saying it fills a medicinal gap in animal health care. She says there are few therapeutic drugs out there for pets, other than human medications poorly adapted for animals. While the clearing from the EU means Creso has the right to sell globally, they are currently searching for a commercial partner to distribute the drug.
If you have an aging or anxiety-ridden pet, it might be time to do some research and call your vet. This new cannabis-based products for pets could be the key to a better quality of life for your best friend.